Prostate Cancer Survivors

 

YANA - YOU ARE NOT ALONE NOW

PROSTATE CANCER SUPPORT SITE

 

 

This forum is for the discussion of anything to do with Prostate Cancer.
There are only four rules:

  • No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
  • No harvesting e-mail addresses for Spam;
  • No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
  • Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making

Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.

Since this is an International Forum, please specify your location in your post.

General Forum
Start a New Topic 
Author
Comment
View Entire Thread
Re: Castion resistant advanced prostate cancer

It sounds like an exciting treatment, but killing all the types of cancer cells one might have is still going to require multi-modal methods:

"Up to a third of those men treated to date show progressive disease despite treatment. This is likely due to a variety of factors. One important factor is whether the tumour cells uniformly express a high density of the PSMA receptor."

"Heterogeneity of PSMA receptor activity within the tumour population may mean that some sites will not respond to treatment with 177Lu PSMA, which will manifest as disease progression, and a rising PSA."

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355374/

Another good thing is that it should be approved very quickly as it involves a drug (now with 177Lutetium attached) that has already been used as a contrast enhancer.

RETURN TO HOME PAGE LINKS